South Korean financial authorities launched a fifth-generation indemnity health insurance product on Wednesday to curb excessive medical utilization [1].
The shift aims to stabilize the insurance market by reducing the financial burden on the majority of policyholders. By limiting coverage for non-essential treatments, the government seeks to prevent the systemic inflation of insurance premiums caused by over-utilization of medical services.
Under the new framework, the system increases support for patients with severe illnesses while tightening restrictions on non-severe, non-reimbursed treatments. For these non-severe treatments, the coverage limit has been reduced from 50 million won to 10 million won [2].
Financial authorities also increased the cost-sharing requirements for patients. The co-payment rate for non-severe, non-reimbursed treatments rose from 30% to 50% [3]. These measures are designed to discourage the use of expensive, non-essential medical procedures that are not covered by the national health insurance system.
To protect those with critical health needs, the plan maintains specific safeguards for high-level care. The annual out-of-pocket maximum for hospitalization at higher-level hospitals is set at 5 million won [4].
Financial authorities said the changes are intended to "prevent the excessive use of unnecessary medical care to reduce the insurance premium burden for the majority of subscribers" [5].
The transition to this fifth-generation model reflects a broader effort by the state to balance patient access to critical care with the long-term sustainability of the private insurance sector.
“The coverage limit for non-severe, non-reimbursed treatments has been reduced from 50 million won to 10 million won.”
This policy shift indicates a strategic move by South Korea to transition from a broad-coverage model to a targeted-benefit system. By increasing co-payments and slashing limits on non-reimbursed treatments, the government is attempting to reduce 'moral hazard'—where insured individuals over-consume medical services because they do not bear the full cost. This may lower premiums for the general population but increases the financial risk for those seeking elective or non-standard treatments.
